Association de la Sommellerie Internationale’s new partner Japan Sake and Shochu Makers Association Invited to General Assembly in Japan
25.7.2022 11:00:00 EEST | Business Wire | Press release
Japan Sake and Shochu Makers Association (hereafter, “JSS") concluded a partnership agreement with the Association de la Sommellerie Internationale (hereafter, “ASI”) in May this year.
JSS exchanged greetings at the ASI general assembly held at the “Nagoya Marriott Associa Hotel” in Japan on July 5 and 6, and joined the welcome dinner held the night before. There they had the opportunity to meet and greet representatives of sommelier associations from 22 countries who were visiting Japan. Welcome dinner cuisine was paired with wine and six varieties of Japanese sake.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220719005658/en/
ASI General Assembly (Graphic: Business Wire)
ASI members were invited to a two-day excursion organized by Mie Sake Brewers Association on July 7 and 8. Participants had the valuable opportunity to tour sake breweries in Mie Prefecture, visit the Ise Grand Shrine that is known for its historical links to sake, and explore the rich history and techniques used to make dashi soup stock at katsuobushi (bonito flakes) production plants.
A sake tasting and discussion event with the member breweries of the Mie Sake Brewers Association, followed by the International Sake Conference in Mie, were held in the evening of July 7 at the “Shima Kanko Hotel,” which attracted worldwide attention in 2016 as the venue for the G7 ISE-SHIMA SUMMIT. A panel discussion led by six panelists including ASI Chairman Wouters covered topics like the potential of Japanese sake as well as international initiatives being planned by JSS.
Representatives from sommelier associations around the world provided a broad range of feedback on how sake could be paired with various styles of cuisines, with many expressing that they would like to try sake with their own country’s culinary specialties.
The reception featured an eight-course meal fusing French cuisine with dashi-inspired flavors and paired with eight local brands of sake, in an ensemble featuring Mie’s three local specialties—ingredients, dashi and sake. This level of hospitality proved to be a source of amazement and inspiration for the leading international sommeliers who had the chance to savor the flavors provided.
The chairs of the Belgian, Serbian, Spanish, and Mexican sommelier associations expressed their desire to work with JSS and schedule sake master classes in the near feature, thus demonstrating the considerable interest that sommeliers have developed for sake.
Looking forward, JSS will coordinate efforts with ASI by providing sake tasting and seminars at events organized by ASI.
Japan Sake and Shochu Makers Association SNS links are as follows.
FB: https://www.facebook.com/japansakeshochu
IG: https://www.instagram.com/japansakeshochu_en/
YouTube: https://www.youtube.com/user/JapanSakeOfficial
Twitter: https://twitter.com/jss_sake_en
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220719005658/en/
Contact information
Japan Sake PR Secretariat
Inquiry person name: Satoru Suzuki
Mail: Japansake@jk-soken.co.jp
FAX: 81-3-5441-2587
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Safe Software to Increase Global Headcount by Over 15% as Demand for AI-Ready Data Grows2.9.2026 16:00:00 EEST | Press release
Safe Software, the creator of FME, the only All-Data, Any-AI enterprise integration platform with true support for spatial data, today announced it is recruiting for more than 60 roles throughout the remainder of 2026. The hiring will take the company past 400 employees, increasing headcount by over 15%, with new positions across the United Kingdom, the United States and Canada. The expansion follows a year in which Safe crossed $100 million in annual revenue, growing close to 20 percent year over year and moving ahead of schedule on its target of $250 million by 2028. The company also grew its employee base by over 20% in the same period. "The incredible growth that we’ve seen over the last 30+ years at Safe has always been a testament to the great people behind what we do," said Don Murray, Co-Founder and CEO of Safe Software. "Almost every organization we speak to is trying to get its data ready for AI, and most of them are realizing that the hard part is not the model, it is the da
Egon Zehnder Names Ayşe Güçlü Onur Global Human Resources Practice Leader2.9.2026 16:00:00 EEST | Press release
Egon Zehnder has appointed Ayşe Güçlü Onur as Global Leader of its Human Resources Practice. This appointment comes as companies and boards increasingly look to CHROs to help shape business strategy, lead transformation, build leadership pipelines, and navigate major shifts in culture and the workforce. "CHROs used to be evaluated by how well they supported the business. Today, the best drive it," said Onur. "Our role is to help CHROs move from a seat at the table to a hand in business growth. We help them connect leadership decisions, talent, and culture directly to elevated performance. That's the shift Egon Zehnder is built to guide with our leadership advisory services." Egon Zehnder’s Human Resources Practice partners with companies to discover, develop, and transform future-ready CHROs, helping them shape the future of the function. This includes executive search, leadership assessment and development, board effectiveness, culture, succession planning, organizational transformati
Owkin to License K Pro AI Scientist and Multimodal Oncology and Immunology Data to Boehringer Ingelheim2.9.2026 15:00:00 EEST | Press release
Owkin, the agentic AI company striving to transform drug discovery and development for biopharma, today announced a license agreement with Boehringer Ingelheim for K Pro, Owkin’s AI Scientist, together with multimodal patient data, aiming to speed up the discovery process across multiple indications in oncology and immunology. This agreement builds upon an initial pilot undertaken by Owkin with Boehringer in 2025. In that pilot Owkin delivered deep spatial insights into the tumor microenvironment of a gene target through its MOSAIC dataset. Under the new agreement, Owkin will license multimodal oncology data to Boehringer and will generate new multimodal data in immunology. Owkin licenses, sources and generates multimodal patient data in collaboration with its global patient data network. Boehringer Ingelheim’s teams will access and analyze this data through K Pro, which provides a single environment to interrogate data and run reproducible analyses. K Pro’s reasoning capabilities supp
Biocytogen Enters into Non-Exclusive Licensing Agreement with Qilu Pharmaceutical for a Fully Human VHH Antibody to Support Innovative Drug Development in Neuroscience2.9.2026 15:00:00 EEST | Press release
Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”, SSE: 688796; HKEX: 02315) today announced that it has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical Co., Ltd. (“Qilu Pharmaceutical”) for a fully human VHH antibody molecule. Under the agreement, Biocytogen will grant Qilu Pharmaceutical non-exclusive rights to a fully human VHH antibody molecule to support its research and development of innovative therapeutics in the neuroscience field. The licensed VHH antibody molecule was generated from Biocytogen’s proprietary RenNano® platform. The RenNano® platform is designed to discover fully human VHH antibody molecules with favorable specificity, binding affinity, and developability, and can generate molecular building blocks for the design and development of VHH antibodies, bispecific/multispecific antibodies, antibody-drug conjugates, and other innovative modalities. Through this license, Qilu Pharmaceutical may advance the research and development o
Croma-Pharma Introduces Electronic Instructions for Use Across the saypha ® Portfolio2.9.2026 14:37:00 EEST | Press release
Croma-Pharma has introduced electronic Instructions for Use (eIFU) across its saypha® portfolio in markets where applicable regulations permit electronic Instructions for Use to replace printed versions. The transition expands digital access to essential product information for healthcare professionals while reducing the use of printed documentation. Healthcare professionals can access the current approved Instructions for Use by scanning the QR code on the saypha® folding box. The eIFU platform provides direct digital access to the latest approved Instructions for Use. "Innovation extends beyond product development. It also includes how we provide healthcare professionals with access to essential product information," said Andreas Prinz, Chief Executive Officer of Croma-Pharma. "The introduction of electronic Instructions for Use across the saypha® portfolio reflects our focus on practical digital solutions that support healthcare professionals and align with evolving regulatory requi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
